Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TNYA stock hub

Tenaya Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TNYAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

217M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TNYA

In the news

Latest news · TNYA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-73.6

P25 -105.6P50 -46.5P75 -3.1

ROIC-43.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TNYA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

194

Groups with data

Currency

USD

Showing 194 of 194 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001858848
Company name	Tenaya Therapeutics, Inc.
Country	United States
Country code	US
Cusip	87990A106
Employees	70
Employees Change	-27%
Employees Change Percent	-27.84
Enterprise value	$146.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-30
Isin	US87990A1060
Last refreshed	2026-05-10
Market cap	$217M
Market cap category	Micro-Cap
Price	$1
Price currency	USD
Rev Per Employee	3,214.29x
Sector	Healthcare
Sic	2836
Symbol	TNYA
Website	https://www.tenayatherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-38.25%
EV/Sales	649.91x
FCF yield	-29.78%
P/B ratio	2.04x
P/S ratio	964.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$225,000
Net Income	$-83M
Net Income Growth Quarters	8%
Net Income Growth Years	2%
Pretax Margin	-36,891.11%
Profit Per Employee	$-1.2M
ROA	-38.46
Roa5y	-35.25
ROCE	-72.58
ROE	-73.59
Roe5y	-65.31
ROIC	-43.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	122.39%
Cagr3y	-47.21%
EPS Growth Quarters	13
EPS Growth Years	5
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$135.1M
Cash	$80.9M
Current Assets	$96.6M
Current Liabilities	$16.8M
Debt	$10.1M
Debt Equity	$0.1
Equity	$106.2M
Liabilities	$28.9M
Long Term Assets	$38.5M
Long Term Liabilities	$12.1M
Net Cash	$70.8M
Net Cash By Market Cap	$32.61
Net Cash Growth	-5.95%
Net Debt Equity	$-0.67
Tangible Book Value	$106.2M
Tangible Book Value Per Share	$0.49
WACC	18.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.75
Net Working Capital	$2M
Quick ratio	5.45
Working Capital	$79.8M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-95.26%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	122.27%
200-day SMA	1.02
3Y total return	-85.29%
50-day SMA	0.74
50-day SMA vs 200-day SMA	50under200
All Time High	32
All Time High Change	-96.88%
All Time High Date	2021-11-08
All Time Low	0.36
All Time Low Change	177.78%
All Time Low Date	2025-05-13
ATR	0.07
Beta	2.77
Beta1y	1.56
Beta2y	2.51
Ch YTD	40.55
High	1
High52	2.35
High52 Date	2025-10-10
High52ch	-57.45%
Low	0.85
Low52	0.36
Low52 Date	2025-05-13
Low52ch	177.78%
Ma50ch	34.41%
Premarket Change Percent	1.3
Premarket Price	$0.86
Premarket Volume	200,732
Price vs 200-day SMA	-2.34%
RSI	71.32
RSI Monthly	41.89
RSI Weekly	54.41
Sharpe ratio	1.23x
Sortino ratio	2.1
Total Return	-95.26%
Tr YTD	40.55
Tr1m	49.79%
Tr1w	41.68%
Tr3m	23.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$6.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.09
Earnings Revenue Estimate	8,000,000x
Operating Income	$-85.9M
Operating margin	-38,159.1
Price target	$5.33
Price Target Change	$433
Price Target Change Top	$550

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	166,770,586%
Float Percent	76.85%
Shares Insiders	0.42%
Shares Institutions	26.96%
Shares Out	216,998,876
Shares Qo Q	23.9%
Shares Yo Y	95.26%
Short Float	15.64%
Short Ratio	8.79
Short Shares	12.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-76.1M
Average Volume	3,702,950.4x
Bv Per Share	0.49
CAPEX	$-246,000
Ch1m	49.79
Ch1w	41.68
Ch1y	122.3
Ch3m	23.23
Ch3y	-85.29
Ch6m	-21.88
Change	17.87%
Change From Open	16.28
Close	0.85
Days Gap	1.37
Depreciation Amortization	7,538,000
Dollar Volume	10,295,623
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-85.9M
EBITDA	$-78.3M
EPS	$-0.47
F Score	1
FCF	$-64.6M
FCF EV Yield	-44.2x
FCF Per Share	$-0.3
Financing CF	57,731,000
Fiscal Year End	December
Founded	2,016
Investing CF	33,770,000
Ipr	-93.33
Iprfo	-94.87
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-11
Ma150	0.99
Ma150ch	0.98%
Ma20	0.75
Ma20ch	34.12%
Net CF	27,115,000
Next Earnings Date	2026-08-05
Open	0.86
Optionable	Yes
Position In Range	100
Post Close	1
Postmarket Change Percent	4
Postmarket Price	$1.04
Ppne	34,723,000
Pre Close	0.85
Price Date	2026-05-08
Ptbv Ratio	2.04
Relative Volume	2.78x
Revenue	225,000x
SBC By Revenue	5,116x
Share Based Comp	11,511,000
Tr6m	-21.88%
Us State	California
Volume	10,295,623

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TNYA pay a dividend?

Capital-return profile for this ticker.

Performance

TNYA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TNYA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+27.0%

Float: +76.9% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TNYA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

71.3

Above 70: short-term overbought

Price vs 200-day MA

-2.3%

50/200-day relationship not available

Beta (5Y)

2.77

More volatile than the market

Sharpe ratio

1.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TNYA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TNYA stock rating?

Tenaya Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TNYA analysis?

The full report lives at /stocks/TNYA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TNYA?

The latest report frames TNYA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TNYA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.